Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!
VBI Vaccines Bilanço Sağlığı
Finansal Sağlık kriter kontrolleri 2/6
VBI Vaccines has a total shareholder equity of $-5.5M and total debt of $48.7M, which brings its debt-to-equity ratio to -891.6%. Its total assets and total liabilities are $75.4M and $80.9M respectively.
Anahtar bilgiler
-891.6%
Borç/özkaynak oranı
US$48.75m
Borç
| Faiz karşılama oranı | n/a |
| Nakit | US$12.60m |
| Eşitlik | -US$5.47m |
| Toplam yükümlülükler | US$80.91m |
| Toplam varlıklar | US$75.44m |
Son finansal sağlık güncellemeleri
Recent updates
VBI Vaccines: Recent Updates Have Fortified My Long-Term Outlook
Sep 22VBI Vaccines gets up to $100M debt funding from K2 HealthVentures
Sep 15Valneva, VBI Vaccines in pact to launch Hep B vaccine in Europe
Sep 08VBI Vaccines down 10% on $300M mixed shelf offering; also ends two equity offerings
Aug 26VBI Vaccines: Recent VBI-1901 Data Supports My Bull Thesis
Jun 17Is VBI Vaccines (NASDAQ:VBIV) A Risky Investment?
Jun 09
Is VBI Vaccines (NASDAQ:VBIV) Using Debt Sensibly?
Jan 24Finansal Durum Analizi
Kısa Vadeli Yükümlülükler: VBIV.Q has negative shareholder equity, which is a more serious situation than short term assets not covering short term liabilities.
Uzun Vadeli Yükümlülükler: VBIV.Q has negative shareholder equity, which is a more serious situation than short term assets not covering long term liabilities.
Borç-Özkaynak Tarihçesi ve Analizi
Borç Seviyesi: VBIV.Q has negative shareholder equity, which is a more serious situation than a high debt level.
Borcun Azaltılması: VBIV.Q's has negative shareholder equity, so we do not need to check if its debt has reduced over time.
Bilanço
Nakit Pist Analizi
Geçmişte ortalama olarak zarar eden şirketler için, en az 1 yıllık nakit akışına sahip olup olmadıklarını değerlendiriyoruz.
İstikrarlı Nakit Pisti: VBIV.Q has sufficient cash runway for 3 months based on last reported free cash flow, but has since raised additional capital.
Tahmini Nakit Akışı: VBIV.Q is forecast to have sufficient cash runway for 3 months based on free cash flow estimates, but has since raised additional capital.